| |
|
|
|
Seres Theraptc  
|
|
8.185 0.205 (0.03%) |
05-23 12:17 |
|
Open: |
7.97 |
Pre close: |
7.98 |
Target:
|
10.14
|
|
High: |
8.22 |
Low: |
7.97 |
Resistance:
|
8.68
9.43
|
|
Volume: |
64,842 |
Market Cap: |
333M |
Support:
|
7.47
6.22
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.29
 |
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
8.15  |
Signal(12,26,9): |
0.07 |
|
MA(100): |
8.96 |
Stochastic Oscillator |
%K(14,3):
|
20.47 |
|
MA(250): |
10.63 |
%D(3): |
38.29 |
|
Average Volume(K) |
3-Month: |
14179
|
52-Week |
High:
|
17.42 |
|
10-Days: |
16817 |
Low: |
6.65 |
|
RSI |
RSI(14):
|
50.23 |
Change(%): |
-14.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.260 |
Return on Equity (ttm) |
-92.5 |
Shares Out. (M) |
40.65 |
|
EPS Est. Current Year |
-2.510 |
Return on Assets (ttm) |
-38.7 |
Shares Float (M) |
39.92 |
|
EPS Est. Next Year |
-2.860 |
PEG Ratio |
0.02 |
% Held by Insiders |
1.80 |
|
EPS Est. Next Quarter |
-0.780 |
Qtrly Rev. Growth |
0.7 |
% Held by Institutions |
64.80 |
|
Forward EPS |
-2.737 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5079 |
|
Book Value (p.s.) |
5.500 |
EBITDA (p.s.) |
-0.790 |
P/E |
-3.62 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.49 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-75.52 |
P/S |
421164896.00 |
|
Operating Margin |
-284.72 |
Levered Free Cash Flow
(M) |
-35.98 |
P/CF |
-4.41 |
|
|
|
|
|
|
